These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25645849)

  • 1. Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax.
    Biron B; Beck K; Dyer D; Mattix M; Twenhafel N; Nalca A
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2206-14. PubMed ID: 25645849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen.
    Henning LN; Carpenter S; Stark GV; Serbina NV
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge.
    Mohamed N; Clagett M; Li J; Jones S; Pincus S; D'Alia G; Nardone L; Babin M; Spitalny G; Casey L
    Infect Immun; 2005 Feb; 73(2):795-802. PubMed ID: 15664918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity.
    Yamamoto BJ; Shadiack AM; Carpenter S; Sanford D; Henning LN; O'Connor E; Gonzales N; Mondick J; French J; Stark GV; Fisher AC; Casey LS; Serbina NV
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5787-95. PubMed ID: 27431222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre- and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax.
    Yamamoto BJ; Shadiack AM; Carpenter S; Sanford D; Henning LN; Gonzales N; O'Connor E; Casey LS; Serbina NV
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5796-805. PubMed ID: 27431219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
    Weiss S; Altboum Z; Glinert I; Schlomovitz J; Sittner A; Bar-David E; Kobiler D; Levy H
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7497-503. PubMed ID: 26392505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added benefit of raxibacumab to antibiotic treatment of inhalational anthrax.
    Migone TS; Bolmer S; Zhong J; Corey A; Vasconcelos D; Buccellato M; Meister G
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1145-51. PubMed ID: 25487792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics cure anthrax in animal models.
    Weiss S; Kobiler D; Levy H; Pass A; Ophir Y; Rothschild N; Tal A; Schlomovitz J; Altboum Z
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1533-42. PubMed ID: 21263056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.
    Peterson JW; Comer JE; Baze WB; Noffsinger DM; Wenglikowski A; Walberg KG; Hardcastle J; Pawlik J; Bush K; Taormina J; Moen S; Thomas J; Chatuev BM; Sower L; Chopra AK; Stanberry LR; Sawada R; Scholz WW; Sircar J
    Infect Immun; 2007 Jul; 75(7):3414-24. PubMed ID: 17452469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of the Efficacy of FDA-Approved
    Couse Z; Cui X; Li Y; Moayeri M; Leppla S; Eichacker PQ
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33450877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raxibacumab for the treatment of inhalational anthrax.
    Migone TS; Subramanian GM; Zhong J; Healey LM; Corey A; Devalaraja M; Lo L; Ullrich S; Zimmerman J; Chen A; Lewis M; Meister G; Gillum K; Sanford D; Mott J; Bolmer SD
    N Engl J Med; 2009 Jul; 361(2):135-44. PubMed ID: 19587338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatment.
    Yee SB; Hatkin JM; Dyer DN; Orr SA; Pitt ML
    Comp Med; 2010 Dec; 60(6):461-8. PubMed ID: 21262133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obiltoxaximab: Adding to the Treatment Arsenal for Bacillus anthracis Infection.
    Hou AW; Morrill AM
    Ann Pharmacother; 2017 Oct; 51(10):908-913. PubMed ID: 28573869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax.
    Kammanadiminti S; Patnaikuni RK; Comer J; Meister G; Sinclair C; Kodihalli S
    PLoS One; 2014; 9(9):e106393. PubMed ID: 25226075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raxibacumab for inhalational anthrax: an effective specific therapeutic approach?
    Antoniu SA
    Expert Opin Investig Drugs; 2010 Jul; 19(7):909-11. PubMed ID: 20450444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity.
    Vitale L; Blanset D; Lowy I; O'Neill T; Goldstein J; Little SF; Andrews GP; Dorough G; Taylor RK; Keler T
    Infect Immun; 2006 Oct; 74(10):5840-7. PubMed ID: 16988263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of anthrax infection with combination of ciprofloxacin and antibodies to protective antigen of Bacillus anthracis.
    Karginov VA; Robinson TM; Riemenschneider J; Golding B; Kennedy M; Shiloach J; Alibek K
    FEMS Immunol Med Microbiol; 2004 Jan; 40(1):71-4. PubMed ID: 14734189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating Anthrax-Induced Meningitis in Rabbits.
    Ben-Shmuel A; Glinert I; Sittner A; Bar-David E; Schlomovitz J; Brosh T; Kobiler D; Weiss S; Levy H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitoxin Treatment of Inhalation Anthrax: A Systematic Review.
    Huang E; Pillai SK; Bower WA; Hendricks KA; Guarnizo JT; Hoyle JD; Gorman SE; Boyer AE; Quinn CP; Meaney-Delman D
    Health Secur; 2015; 13(6):365-77. PubMed ID: 26690378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.